INSIGHTS ON SOLID DOSE MANUFACTURING
-
The Critical Role Of Weight Uniformity In Tablet Manufacturing
For tablet manufacturers, tablet weight uniformity plays an essential role in ensuring pharmaceutical products deliver accurate amounts of key ingredients in a formulation.
-
Developing And Manufacturing Drugs With HPAPIs
Learn why companies must invest in specialized expertise to develop scalable, safe, and efficient manufacturing processes for highly potent oral solid dose products.
-
Closing The Duration Gap In FDA-Approved Long-Acting Contraceptives
A gap exists between three months and three years in FDA-approved long-acting contraceptives (LACs). A microsphere formulation enables sustained release over a six to twelve-month period.
-
The Future Of Pharma Packaging Trends, Technologies, And Patient-Centric Solutions
Pharmaceutical packaging must evolve alongside drug development to ensure stability, safety, and regulatory adherence, utilizing innovative designs to improve therapeutic outcomes and patient accessibility.
-
High Potency APIs And The Evolving Demands Of Drug Development4/13/2026
See how higher API activity is changing expectations around containment, scalability, and cross‑functional alignment — and why early decisions now have a greater impact on long‑term success.
-
Integration From Formulation Development To Manufacturing, Packaging2/27/2025
Adare Pharma Solutions' Pessano, Italy facility offers 220,000 sq. ft. of end-to-end services, including R&D, formulation development, clinical and commercial manufacturing, packaging, and advanced analytical capabilities.
-
Contract Pharma 2026: Mikart On CDMO Collaboration4/30/2026
An overview of a milestone pharmaceutical outsourcing conference focused on CDMO collaboration, tech transfer, and oral solid and liquid dose manufacturing strategies.
-
Less Mess, Less Stress, Best Expressed: An Alternative To Spray Drying7/16/2024
Although well-established processes, spray drying and hot-melt extrusion can be outperformed in bioavailability, cost-savings, manufacturing speed, environmental impact, and more.
-
Navigating High-Potency OSD Manufacturing4/13/2026
Learn how containment strategy, process design, and early risk‑based decisions influence operator protection, compliance, and long‑term manufacturing success as potency levels continue to rise.
SOLID DOSE MANUFACTURING SOLUTIONS
-
Used Elizabeth Hata R&D tablet press, model EP200, B/D tooled with 10 station turret, 5 stations each B and D, 16 mm B, 22 mm D max tablet diameter, 17 mm B, 18 mm D max depth of fill, rated up to 6000 tablets/hour, with feed hoppers and feed frames, Machine #81, built 2011.
-
Used GlobePharma MiniBlend twin shell blender, model MNB-1 with 2 quart, 1 quart, and 0.5 quart stainless steel shells, t V-Cones, .1 hp 110 volt motor, serial# 12098879.
-
In pharmaceutical manufacturing containment performance is critical to minimize operator exposure and process cross contamination.
-
Used BWI Manesty Unipress Diamond rotary table press, 27 station, keyed upper punch guides, 6.5 ton main compression, 1 ton pre compression, B tooled, 16 mm max tablet diameter, 18 mm max depth of fill, single side with force feeder with feed hopper, rated up to 196,200 tablets/hour, serial# UN248JA.
-
ROSS Ribbon Blenders efficiently mix powders, granules, and bulk solids across industries, offering customizable lab-to-production models for various bulk densities, including heavy-duty and sanitary applications.